In some embodiments, the otic formulation or composition comprises about 20% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
Key reports on ME/CFS have shown abnormal metabolites produced which demonstrate disturbed Amino Acid metabolism, dysregulated lipid metabolism with possible glycolysis impairment, possible Pyruvate Dehydrogenase (PDH) impairment, Urea Cycle dysregulation and overall TCA cycle substrates provision deficiency and reliance these cells for alternate fuel sources
123,181,182,183,184 Consequently, diminishing APOE4 expression in A plaque-associated microglia may offer an effective approach
A 10mg vial provides 10mg of total blend, which scales with use but once reconstituted, the material has a finite stable window